Tudor Investment Corp ET AL Acquires Shares of 44,633 Omada Health, Inc. $OMDA

Tudor Investment Corp ET AL bought a new position in Omada Health, Inc. (NASDAQ:OMDA) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 44,633 shares of the company’s stock, valued at approximately $987,000. Tudor Investment Corp ET AL owned about 0.08% of Omada Health at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in OMDA. Cigna Investments Inc. New bought a new position in shares of Omada Health during the 3rd quarter worth $76,161,000. Perceptive Advisors LLC bought a new stake in Omada Health in the 2nd quarter valued at about $44,402,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health during the third quarter valued at about $30,510,000. Loomis Sayles & Co. L P purchased a new stake in Omada Health during the second quarter valued at about $19,948,000. Finally, BIT Capital GmbH bought a new position in Omada Health during the third quarter worth about $13,639,000.

Analysts Set New Price Targets

Several analysts have recently issued reports on OMDA shares. Barclays lowered their price target on shares of Omada Health from $22.00 to $17.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Canaccord Genuity Group reduced their price objective on shares of Omada Health from $28.00 to $22.00 and set a “buy” rating for the company in a research note on Friday, March 6th. The Goldman Sachs Group reissued a “buy” rating and set a $26.00 target price on shares of Omada Health in a report on Friday, January 16th. Finally, Morgan Stanley cut their price target on Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Friday, March 6th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and a consensus price target of $23.60.

Omada Health Stock Up 1.7%

Shares of OMDA opened at $12.05 on Tuesday. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $28.40. The stock has a market cap of $709.99 million and a PE ratio of -70.88. The business’s 50-day moving average price is $13.35 and its 200-day moving average price is $17.62.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, March 5th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.12. The firm had revenue of $75.85 million during the quarter.

Insider Activity at Omada Health

In other Omada Health news, CFO Steven L. Cook sold 1,884 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $13.94, for a total value of $26,262.96. Following the completion of the transaction, the chief financial officer directly owned 200,512 shares of the company’s stock, valued at $2,795,137.28. This trade represents a 0.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the transaction, the chief executive officer owned 117,598 shares of the company’s stock, valued at $1,686,355.32. This trade represents a 3.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 277,222 shares of company stock worth $4,330,695 over the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.